USPTO serial 76270173
HIBERGEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUSH, KAREN K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HIBERGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bray, County Wicklow, IE
Bray, County Wicklow, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert J. Kenney
ROBERT J KENNEY BIRCH STEWART KOLASCH & BIRCH LLPP O BOX 747FALLS CHURCH, VA 22040-0747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Preparations for use in medical analysis, diagnosis and research, namely, microarrays of nucleotides, nucleic acids and olignucleotides applied to plastic chips, substrates and supports optionally also carrying buffers, chemical reagents, flourescents compounds, florescent-labelled compounds all for use in medical research, pharmaceutical research, veterinary research, genotyping, detection of mutation and polymorphisms, the determination of the genetic basis of disease, the determination of the genetic basis of drug response, and the analysis, characterization and identification of nucleic acids; analytical and diagnostic kits comprising buffers, chemical reagents, florescent compounds, florescent-labelled compounds, nucleotides, nucleic acids, oligonucleotides all for use in medical research, pharmaceutical research, veterinary research, genotyping, detection of mutations and polymorphisms, the determination of genetic basis of drug response, and the analysis, characterization and identification of nucleic acids | ACTIVE | — |
| 005 | Analytical and diagnostic kits comprising buffers, chemical reagents, fluorescent compounds, fluorescent-labelled compounds, nucleotides, nucleic acids, oligonucleotides all for use in medical diagnosis and testing of clinical samples; pharmaceutical preparations and substances for the treatment of complex diseases, namely, heat disease, psychiatric disorders, diabetes, inflammatory diseases, osteoporosis, arthritis, pre-eclampsia, pulmonary diseases and cancer; preparations for use in medical analysis, diagnosis and research, namely, microarrays, macroarrrays of nucleotides, nucleic acids and olingnucleotides applied to plastic chips, subrates and supports optionally also carrying buffers, chemical reagents, florescent compounds, florescent-labelled compounds all for use in medical diagnosis and testing of clinical samples | ACTIVE | — |
| 042 | Medical diagnosis, testing of clinical samples, medical research, detection of pathogens, identification of pathogens, diagnosis of disease, diagnosis of infection, veterinary research, genotyping, detection of mutations and polymorphisms, gene expression profiling, determination of the genetic basis of disease, determination of the genetic basis of drug response, nucleic acid analysis, nucleic acid characterization, nucleic acid identification, plant research, and human genome analysis; providing a genetic database | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HiberGen Limited
- Other trademarks owned by HiberGen Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named HIBERGEN
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 12, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 20, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 30, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 5, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2003 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 13, 2003 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 11, 2003 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 31, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2002 | PAPER RECEIVED | — | |
| Sep 12, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 1, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2001 | DOCK | ASSIGNED TO EXAMINER | — |